Category:Medication templates
From HandWiki
Revision as of 16:48, 18 October 2021 by imported>MainEditor (Created page with "{{Maintenance category|hidden=yes}} {{polluted category}}")
 | This is a maintenance category, used for maintenance of the HandWiki project. It is not part of the encyclopedia and contains pages, or groups articles by status rather than subject. Do not include this category in content categories.
This is a hidden category. It is not shown on its member pages, unless the corresponding user preference (appearance → show hidden categories) is set. |
Pages in category "Medication templates"
The following 59 pages are in this category, out of 59 total.
A
- Template:Absolute activities of tibolone and metabolites
- Template:Affinities of 5α-dihydroethisterone for steroid hormone proteins
- Template:Affinities of a selection of androgen receptor ligands at steroid hormone receptors
- Template:Affinities of dydrogesterone and related steroids
- Template:Affinities of estrogen receptor ligands for the ERα and ERβ
- Template:Affinities of selected androgen receptor ligands
- Template:Affinities of selected ligands at the androgen receptor
- Template:Androgen replacement therapy formulations and dosages used in men
- Template:Androgen replacement therapy formulations and dosages used in women
- Template:Androgen/anabolic steroid dosages for breast cancer
- Template:Antiandrogens marketed for clinical or veterinary use
- Template:Available forms of estradiol
E
M
P
- Template:Parenteral durations of androgens/anabolic steroids
- Template:Parenteral potencies and durations of nonsteroidal estrogens
- Template:Parenteral potencies and durations of progestogens
- Template:Pharmacodynamics of aromatase inhibitors
- Template:Pharmacokinetics of 100 mg per day spironolactone and its metabolites
- Template:Pharmacokinetics of long-acting injectable antipsychotics
- Template:Pharmacokinetics of testosterone esters
- Template:Pharmacokinetics of three estradiol esters by intramuscular injection
- Template:Potencies and durations of natural estrogens by intramuscular injection
- Template:Protein binding and metabolic clearance rates of estrogens
R
- Template:Relative activities of estradiol and related estrogens at the estrogen receptors
- Template:Relative affinities and uterotrophic efficacies of estrogens
- Template:Relative affinities of antiandrogens at steroid-hormone receptors
- Template:Relative affinities of estradiol and related estrogens at steroid hormone proteins
- Template:Relative affinities of first-generation nonsteroidal antiandrogens for the androgen receptor
- Template:Relative affinities of hydroxyprogesterone and related steroids
- Template:Relative affinities of levonorgestrel and metabolites
- Template:Relative affinities of nandrolone and related steroids
- Template:Relative affinities of nandrolone and related steroids at the androgen receptor
- Template:Relative affinities of norethisterone, metabolites, and prodrugs
- Template:Relative affinities of noretynodrel, tibolone, and metabolites
- Template:Relative androgenic to anabolic activity in animals
- Template:Relative oral potencies of estrogens
- Template:Relative potencies of selected antiandrogens
- Template:Results of the Women's Health Initiative menopausal hormone therapy randomized controlled trials
- Template:Risk of breast cancer with menopausal hormone therapy by duration in large observational studies
- Template:Risk of breast cancer with menopausal hormone therapy in large observational studies
- Template:Risk of venous thromboembolism with hormone therapy and birth control pills (QResearch/CPRD)
